Fresh analysis indicates that individuals who stop using new slimming jabs like Mounjaro or Wegovy tend to recover shed pounds far faster than those who halt conventional lifestyle regimens.
Research printed in a prominent medical journal points out that while overweight individuals frequently drop a large proportion of their total mass while using the jabs, the mass returns at an estimated rate of nearly a kilo each month upon discontinuation.
"Users buying these treatments should be cognizant of the danger of fast weight regain when the medication is stopped," cautioned expert Dr. Susan Jebb.
Such speed of regain suggests a reversion to original weight in about a year and a half.
Comparing Treatments
The research, which reviewed 37 of studies involving over 9,000 of participants, contrasted the effects of GLP-1 agonists with other pills.
Scientists emphasize that individuals who shed pounds through lifestyle changes alone generally see a less rapid creep back—approximately 0.1 kg a month—once they finish.
Explaining the Quick Regain
Nutrition scientists suggest the way of the drugs explains the accelerated rebound.
The injections imitate a body's own chemical called GLP-1, which helps regulate hunger.
"Artificially providing the hormone concentrations far above than the body's typical production might result in the system to produce less of its own natural GLP-1, and could lessen sensitivity to its effects," said Dr. Adam Collins, a nutrition expert.
"Stopping of this hormone supplement means appetite is no longer kept in check, making overeating a significant risk."
An Ongoing Condition?
The NHS advise the jabs for individuals with obesity-related health risks, accompanied by prescribed lifestyle changes.
A number of clinicians argue that, given the high risk of weight regain, the therapy is often ongoing.
This view is supported by drug manufacturers, who say that the results "underscore the chronic nature of excess weight," comparing it to managing diseases like hypertension.
User Experiences
Individuals who have discontinued the medication describe a intense resurgence of cravings.
"It felt as if a switch activating and you're instantly ravenous," said a patient.
This difficulty is compounded if individuals have not adopted permanent lifestyle or habit modifications during therapy.
Significant Adoption
Survey data show that a significant number of adults in the UK have used these injections in the last 12 months, with interest remaining high.
- Use is greater among women compared to males.
- The 40s and 50s age group shows the greatest level of interest.
- Many obtain the drugs through private prescriptions rather than the NHS.
Finally, researchers stress that while GLP-1 drugs are effective tools for weight loss, they are not a magic fix and long-term success hinges on integrated lifestyle support.
